• Most Popular
  • Most Shared

Australia's CSL to buy Talecris for $3.1 bln

Tue Aug 12, 2008 7:25pm EDT

Stocks

   

SYDNEY, Aug 13 (Reuters) - Australia's CSL Ltd (CSL.AX), the world's top maker of plasma products, has agreed to buy Talecris Biotherapeutics Holdings Corp, a plasma therapeutics business, for A$3.48 billion ($3.1 billion), CSL said in a statement on Wednesday.

Stocks  |  Mergers & Acquisitions  |  IPOs  |  Global Markets

CSL plans to raise $1.5 billion through an institutional share placement to part-fund the deal. ($1=A$1.15) (Reporting by Denny Thomas;) ((denny.thomas@reuters.com; +61 2 9373 1812; Reuters Messaging: denny.thomas.reuters.com@reuters.net))
Stocks
Mergers & Acquisitions
IPOs
Global Markets


More from Reuters

Photo

Employers see uptick in hiring in 2010

NEW YORK (Reuters) - U.S. employers expect to hire more new workers in 2010 than they did in 2009, a sign the U.S. recession may be easing its grip, research showed on Tuesday.

» More Top News
An employee swipes a customer's credit card through the card reader at a restaurant in Tokyo February 19, 2005.REUTERS/Issei Kato

Taking a swipe at credit cards

New legislation meant to protect consumers could be a "game changer" for the industry -- and not in a good way.  Full Article 

Economy
dealer shuffles a deck of cards during a poker game at a casino in Budapest September 15, 2009. REUTERS/Katoly Arvai

Placing their bets

Two IPO filings will test investors' appetite for risk that they probably would've avoided in the past year.  Full Article 

DEALS